Referred to the House Committee on Energy and Commerce.
The bill amends the Federal Food, Drug, and Cosmetic Act to authorize the HHS Secretary to share unredacted FDA food-safety information with State, local, Tribal, and Territorial authorities.
It lists types of information eligible for sharing, sets timing and limited re‑disclosure rules, and preserves other confidentiality agreements.
Separately, it lengthens certain food-safety grant award periods from three to five years and makes continued funding contingent on a first-year program evaluation.
Content is technical and broadly defensible for public health; confidentiality and stakeholder concerns create moderate uncertainty.
Relative to its intended legislative type, this bill clearly establishes a substantive change to federal authority by adding a statutory authorization for FDA to share unredacted food safety information with State, local, Tribal, and Territorial authorities and by lengthening certain grant terms. The statutory amendments are explicit and integrated with existing FD&C Act provisions, but the bill leaves significant operational and resourcing details to implementation.
Progressives emphasize public health gains and privacy safeguards
Progressives emphasize public health gains and privacy safeguards
Generally favorable: improved, faster data sharing should strengthen outbreak response and protect public health.
Will seek stronger privacy, Tribal consultation, and worker/consumer protections tied to implementation and funding.
Cautious support: the bill clarifies legal authority for information sharing and increases grant stability.
Prefers clearer definitions, oversight, and funding assurances to limit unintended consequences.
Skeptical: while state access to information can aid public health, the bill expands federal authority and risks disclosure of proprietary data.
Support conditional on stronger limits and protections.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is technical and broadly defensible for public health; confidentiality and stakeholder concerns create moderate uncertainty.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize public health gains and privacy safeguards
Content is technical and broadly defensible for public health; confidentiality and stakeholder concerns create moderate uncertainty.
Relative to its intended legislative type, this bill clearly establishes a substantive change to federal authority by adding a statutory authorization for FDA to share unredacted food safety information with State, loca…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.